United Arab Emirates Vaccine Packaging Market Size & Outlook, 2026-2034
United Arab Emirates Vaccine Packaging Market Insights
- As per Packaging Market Insights, the United Arab Emirates Vaccine Packaging Market stood at USD 42.05 Million in 2025 and is anticipated to grow to USD 68.98 Million by 2034.
- The United Arab Emirates market is expected to advance at a CAGR of 5.63% from 2026 through 2034.
- In 2025, Plastics accounted for the highest share of the By Material market size.
- During the forecast period, Glass is set to register the highest growth, making it the most lucrative By Material segment.
Source: PIAnalysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, United Arab Emirates held 3.53% of the global Vaccine Packaging Market size.
- By 2034, United States is anticipated to capture the largest share of the global Vaccine Packaging Market.
- In Middle East and Africa, United Arab Emirates is expected to lead the regional Vaccine Packaging Market size by 2034.
- Egypt will remain the fastest-growing market in Middle East and Africa, reaching USD 17.46 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 42.05 Million |
| Market Size In 2034 | USD 68.98 Million |
| Largest segment | Plastics |
| Units | Revenue in USD Million |
| CAGR | 5.63% (2026-2034) |
| Segmnetation Covered | |
| By Material |
|
| By Type |
|
| By End-Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Arab Emirates Vaccine Packaging Market By Material 2026-2034 (USD Million)
| By Material | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plastics | XX.x | XX.x | XX.x | 22.35 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Glass | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
United Arab Emirates Vaccine Packaging Market By Type 2026-2034 (USD Million)
| By Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glass Vials | XX.x | XX.x | XX.x | 14.9 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Prefillable Syringes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Vial Closures | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Secondary Vaccine Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
United Arab Emirates Vaccine Packaging Market By End-Use 2026-2034 (USD Million)
| By End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic Centers | XX.x | XX.x | XX.x | 19.92 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Clinical Research Organizations (CROs) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.